
Health
Berwyn, Pennsylvania–(Newsfile Corp. – May 10, 2021) – Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, is pleased to announce that ... [Read]